glp 1 receptor list Table 1 from Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists Every GLP-1 Agonist Drug You

Track results carefully to find your optimal approach

Cardiovascular and kidney outcomes GLP-1 medications offer meaningful heart and kidney protection

Typical 12-month results include 10 to 15% body weight loss (20 to 35 pounds for a 200-pound person), 2 to 4 inch waist circumference reduction, noticeable improvement in body composition especially with exercise, and significant improvement in metabolic markers if they were elevated

The weight loss achieved varies by specific medication and dose: semaglutide 2.4 mg (Wegovy) produces approximately 15% weight loss, tirzepatide (Zepbound) up to 15-22%, and liraglutide 3 mg (Saxenda) about 5-8%